Le Lézard
Classified in: Health
Subject: AWD

The Inner Circle acknowledges Rumpa Amornmarn, MD as a Pinnacle Lifetime Member


KISSIMMEE, Fla., March 26, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Rumpa Amornmarn, MD is acknowledged as a Pinnacle Lifetime Member for her contributions to the Radiation Oncology industry.

Dr. Amornmarn, a highly respected and board-certified specialist in cancer treatment, stands as a dedicated advocate for her patients' well-being. With an unwavering commitment to saving lives and helping patients regain their everyday activities, she has earned a distinguished reputation in the medical field.

Dr. Amornmarn specializes in the treatment of cancer patients, with a particular focus on breast and prostate cancers. As the President of her private practice, she leads by example, supervising all medical staff, managing financial aspects, and ensuring optimal division performance. Her exceptional leadership and expertise drive her practice's success.

Dr. Amornmarn's expertise extends to intensity-modulated radiation therapy, a cutting-edge approach that offers precise and effective cancer treatment. Her commitment to staying at the forefront of medical advancements ensures her patients receive the best care possible.

Dr. Amornmarn maintains affiliations with esteemed organizations, including the American Society of Therapeutic Radiology and Oncology, the American College of Radiology, The Radiologic Society, the American Society of Clinical Oncology, Johns Hopkins Medical and Surgical Society, and the Johns Hopkins Medical Alumni Association. These affiliations reflect her dedication to professional development and knowledge sharing within the medical community.

Dr. Amornmarn's journey in medicine began with pre-medical studies at Chulalongkorn University in Bangkok, Thailand. She earned her MD degree from Siriraj Medical School/Mahidol University in Thailand and further honed her skills through residencies in internal medicine at the Veterans Affairs Hospital in Washington, DC, as well as therapeutic radiology and a fellowship in radiology and oncology, both completed at Johns Hopkins University. Her board certification in radiology underscores her expertise.

Dr. Amornmarn's commitment to advancing cancer treatment is evident in her contributions to the field. She has authored numerous presentations and contributed more than 25 articles to professional journals, further solidifying her position as a thought leader in her domain.

Dr. Amornmarn's unwavering dedication to her patients remains her driving force. She envisions continuing her vital work while continually seeking improvements in medical care to better serve her patients.

Dr. Amornmarn honors her parents, Che Penty, and Mecho Mai, in her pursuit of excellence. In her personal life, she has been married to Mr. Surachai Sutha for 43 years, and they have one son.

Dr. Amornmarn's impressive career spanning over four decades is a testament to her passion for cancer treatment and her commitment to making a meaningful difference in the lives of her patients.

Contact: Katherine Green, 516-825-5634, [email protected]

SOURCE The Inner Circle


These press releases may also interest you

at 08:30
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...



News published on and distributed by: